First published 9/28/2026, 8:07:15 AM · Last updated 9/28/2026, 8:07:15 AM

QbD Enabled Chebulinic Acid Solid Dispersions Encapsulated in Modified Xanthan Gum Coated Sodium Alginate Beads for Enhanced Gastric Ulcer Therapy

A Springer journal article published 2026-04-24 describes development of chebulinic acid solid dispersions encapsulated in modified xanthan gum‑coated sodium alginate beads intended to improve gastric ulcer therapy. The supplied source data include only the title, publisher, and publication date and provide no experimental results, location, or impact metrics.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 3/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 2/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 7/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article pertains to a potential therapeutic formulation for gastric ulcers but the source provides no outcome or impact details.

Sources

QbD Enabled Chebulinic Acid Solid Dispersions Encapsulated in Modified Xanthan Gum Coated Sodium Alginate Beads for Enhanced Gastric Ulcer Therapy

Report an issue